__NUXT_JSONP__("/drugs/Epratuzumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"205923-57-5",chebiId:b,chemicalFormula:b,definition:"A recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells.  After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC).",fdaUniiCode:"3062P60MH9",identifier:"C1887",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["EPRATUZUMAB",a,"Humanized Anti-CD22 Monoclonal Antibody IgG1","LymphoCide","epratuzumab","hLL2"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEpratuzumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Epratuzumab","","2021-10-30T13:37:04.783Z")));